Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.2939
-0.0027-0.91%
Last update: Oct 9, 4:57 PM
$0.2940
-0.0026-0.88%
Kala Bio Inc (KALA) Stock Price, Quote, News & History
KALANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kala Bio (NASDAQ:KALA) through any online brokerage.
Other companies in Kala Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Kala Bio has a consensus price target of $1300.00.
The stock price for Kala Bio (NASDAQ: KALA) is $0.294 last updated October 9, 2026 at 4:57 PM EDT.
There are no upcoming dividends for Kala Bio.
Kala Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Kala Bio.
Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
